No phaseActive, not recruiting
CART-BP Prospective Study for Hypertension Control
Efficacy and Safety of Cuffless Ambulatory Blood Pressure Monitoring Device-Guided Blood Pressure Management in Korean Patients With Uncontrolled Hypertension: A Prospective Non-Randomized Study
- Sponsor
- Korea University Anam Hospital (Academic or other)
- Enrolment
- 288 enrolled
- Conditions
- Hypertension
- Interventions
- CART BP pro; Usual care (office BP-based management)
- Ages
- adults, older adults
- Registry
- NCT07454148
Full record on ClinicalTrials.gov
From the registry
This prospective, open-label, non-randomized study evaluates the effectiveness and safety of a CART BP pro(a brand name of cuffless ambulatory blood pressure monitoring device)-guided blood pressure management strategy in Korean patients with uncontrolled hypertension. Participants are allocated to either a CART BP pro-guided management group or a usual care group based on clinical decision and participant preference. The primary efficacy endpoint is 24-hour mean ambulatory systolic blood pressure at 24 weeks; safety outcomes including treatment-emergent adverse events (TEAEs) are also assessed.
Primary outcomes
- 24-hour mean systolic blood pressure
History
Primary completion
Last registry update
Registered
Started